BioNTech SE (BNTX) Tops Q3 EPS by 236c
Tweet
Share
E-mail
Get Alerts BNTX Hot Sheet
Join SI Premium – FREE
BioNTech SE (NASDAQ: BNTX) reported Q3 EPS of EUR0.81, EUR2.36 better than the analyst estimate of (EUR1.55). Revenue for the quarter came in at EUR1.24 billion versus the consensus estimate of EUR565.56 million.
For earnings history and earnings-related data on BioNTech SE (BNTX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
- Enanta Pharma loses appeal in Pfizer Paxlovid patent case
- Alphabet to replace Verizon in the Dow Jones Industrial Average
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
